Abstract:DEAR EDITOR, Allergic contact dermatitis to hair-dye-related molecules represents a considerable health concern. para-Phenylenediamine (PPD) is considered a key sensitizer in hairdye-related allergic contact dermatitis. Mechanistically, oxidation of PPD was found to be of great importance for the induction of sensitization. Moreover, PPD can be N-acetylated by N-acetyltransferase (NAT)1 to monoand diacetylated PPD in skin, while other conjugates were rarely detected. N-Acetylated PPD metabolites were classified as nonsensitizers in the murine local lymph node assay. We demonstrated by in vivo Raman spectrometry that free PPD indeed reaches the viable human epidermis. The N-acetylation in skin relies mainly on keratinocytes. We and others have shown that NAT1 activity is particularly high in proliferating cells, suggesting that the formation of N-acetylated PPD derivatives may occur in proliferating keratinocytes from basal layers rather than in differentiated keratinocytes from the outer layers. Such a spatial distribution of NAT1 in the epidermis could be of particular importance, as the formation of nonsensitizing PPD metabolites offers protection against exposure to sensitizing derivatives. If NAT1 is indeed active only in basal, proliferating keratinocytes, dendritic cells in differentiated epidermal layers (suprabasal Langerhans cells) would be less protected and more likely exposed to PPD and sensitizing oxidative PPD derivatives than those in the basal epidermal layers (basal Langerhans cells) and dermis. However, if nonsensitizing N-acetylated PPD derivatives were formed immediately after PPD enters the viable epidermis, protection would be reinforced. Thus, N-acetylation in differentiated epidermal layers could influence the exposure to sensitizing derivatives and thereby activation of keratinocytes and dendritic cells, both important steps in the course of sensitization and elicitation of allergic contact dermatitis. However, knowledge about the enzymatic activities of NAT1 in differentiated keratinocytes is lacking. Therefore, we analysed the presence and localization of NAT1 protein in human reconstructed epidermis and ex vivo human skin using an anti-NAT1 antibody (1 : 100; and Alexa Fluor 555-labelled secondary antibody, 1 : 400). NAT1 was found to be expressed throughout the epidermis up to the outermost viable layers (Fig. 1a). To compare the NAT1 enzyme activities and metabolic turnover in the different layers, we used normal human primary keratinocytes (NHEKs, four donors) and HaCaT cells. Differentiation was induced by 5 days (NHEK) or 14 days (HaCaT) of calcium chloride (2 mmol L ) treatment and was confirmed by upregulation of KRT1 and FLG. NAT1 and KRT14 mRNA levels were unaltered (NHEK, Fig. 1b; HaCaT, data not shown). Cellular NAT1 enzyme activity measurement (excess cofactor, 30 min) showed similar values for cell homogenates from proliferating and differentiated NHEKs (Fig. 1c). In accordance with skin staining we detected NAT1 protein (Alexa Fluor 488labelled secondary antibody, 1 : 2000) in proliferating and differentiated NHEKs (Fig. 1d). Substrate-dependent reduction of enzymatic activity, a known property of NAT1, was used to characterize NAT1 further using HaCaT cells. In line with the results for NHEKs, nontreated proliferating and differentiated HaCaT cells showed similar activities (Fig. 1e). In addition, cell treatment with the known substrates PPD or para-aminobenzoic acid resulted in a 50% reduction of NAT1 activity. We and others have demonstrated that skin cells express low levels of NAT2 mRNA but have no detectable NAT2 activity. We confirmed our findings for proliferating cells and also found no NAT2 activity in differentiated HaCaT cells (Fig. 1f). To evaluate PPD uptake and conversion by keratinocytes from differentiated layers, we analysed PPD N-acetylation in the cellular context of proliferating NHEKs and different states of differentiation. Proliferating keratinocytes, and also keratinocytes in early, intermediate and even late states of differentiation, were able to release N-acetylated PPD at all time points. Although this was not statistically significant, the released amounts of N-acetylated PPD were on average highest in late differentiated keratinocytes of every donor (Fig. 1g, h). As the NAT activities of the cell homogenates clearly indicated similar capacities of NAT1 and no NAT2 activity, other cellular changes in the course of differentiation, leading to different substrate availability or variability of the endogenous cosubstrate level, could have influenced the substrate conversion. In summary, we showed similar mRNA, protein and enzyme activity of NAT1, as well as absence of NAT2 activity, in the course of differentiation. For the first time we have demonstrated that substrate uptake and turnover, as well as release of converted metabolites, is performed even by differentiated viable keratinocytes at a late stage. These data show that N-acetylation of PPD and thereby formation of nonsensitizing metabolites can occur immediately upon PPD reaching the viable epidermis. This is considered of particular importance for local effects, for instance activation

D2 dopamine receptor involvement in the rough-and-tumble play behavior of juvenile rats.

Clinical Relevance and Prognostic Value of the Neuronal Protein Neuroligin 2 in Breast Cancer

Glycoprotein Hormone Α‑subunit Promotes Cell Proliferation and Tumorigenesis in Breast Cancer

Tumor and Serum Gamma-Glutamyl Transpeptidase, New Prognostic and Molecular Interpretation of an Old Biomarker in Gastric Cancer

Tissue Transglutaminase 2 Exerts a Tumor-Promoting Role in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Transglutaminase 2 in breast cancer metastasis and drug resistance

Hand contamination before and after different hand hygiene techniques: a randomized clinical trial.

Increased Expression of TMED2 is an Unfavorable Prognostic Factor in Patients with Breast Cancer

Indexing of medical literature.

Identification of Glycolysis-Associated Long Non-Coding RNA Regulatory Subtypes and Construction of Prognostic Signatures by Transcriptomics for Bladder Cancer

KBTBD2 promotes proliferation and migration of gastric cancer via activating EGFR signaling pathway

Transcriptomics studies reveal functions of Transglutaminase 2 in breast cancer cells using membrane permeable and impermeable inhibitors

P3.16-01 A Multi-Omic Study Reveals BTG2 As a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

Biology of Human Tumors TMEFF 2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis

Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer

[Effect of fertilization on phenolic components and antioxidant activities of Artemisia annua].

Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer

TLK2 promotes progression of hepatocellular carcinoma through Wnt/β-catenin signaling

Functional expression of N‐acetyltransferase 1 in differentiated human skin keratinocytes

Can median nail dystrophy be an adverse effect of alitretinoin treatment?